RESUMEN
Matrine and sophocarpine are two major matrine-type alkaloids included in the traditional Chinese medicine (TCM) Kushen (the root of Sophora flavescens Ait.). They have been widely used clinically in China, however with few reports concerning their potential toxicities. This study investigated the developmental toxicity and neurotoxicity of matrine and sophocarpine on zebrafish embryos/larvae from 0 to 96/120h post fertilization (hpf). Both drugs displayed teratogenic and lethal effects with the EC50 and LC50 values at 145 and 240mg/L for matrine and 87.1 and 166mg/L for sophocarpine, respectively. Exposure of matrine and sophocarpine significantly altered spontaneous movement and inhibited swimming performance at concentrations below those causing lethality and malformations, indicating a neurotoxic potential of both drugs. The results are in agreement with most mammalian studies and clinical observations.
Asunto(s)
Alcaloides/toxicidad , Cardiotoxinas/toxicidad , Neurotoxinas/toxicidad , Quinolizinas/toxicidad , Teratógenos/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Embrión no Mamífero/anomalías , Embrión no Mamífero/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Miocardio/patología , Notocorda/anomalías , Cola (estructura animal)/anomalías , Pez Cebra/anomalías , MatrinasRESUMEN
Ginseng is one of the most widely used medicinal plants, which belongs to the genus Panax. Compared to uncured white ginseng, red ginseng has been generally regarded to produce superior pharmacological effects with lesser side/adverse effects, which made it popular in a variety of formulation from tea to oriental medicine. Using the prenatal valproic acid (VPA)-injection model of autism spectrum disorder (ASD) in rats, which produces social impairrment and altered seizure susceptibility as in human ASD patients as well as mild neural tube defects like crooked tail phenotype, we examined whether chronic administration of red ginseng extract may rescue the social impairment and crooked tail phenotype in prenatally VPA-exposed rat offspring. VPA-induced impairment in social interactions tested using sociability and social preference paradigms as well as crooked tail phenotypes were significantly improved by administration of Korean red ginseng (KRG) in a dose dependent manner. Rat offspring prenatally exposed to VPA showed higher sensitivity to electric shock seizure and increased locomotor activity in open-field test. KRG treatment reversed abnormal locomotor activity and sensitivity to electric shock to control level. These results suggest that KRG may modulate neurobehavioral and structural organization of nervous system adversely affected by prenatal exposure to VPA.
Asunto(s)
Trastornos Generalizados del Desarrollo Infantil/tratamiento farmacológico , Defectos del Tubo Neural/tratamiento farmacológico , Panax/química , Extractos Vegetales/farmacología , Ácido Valproico/efectos adversos , Animales , Conducta Animal/efectos de los fármacos , Niño , Trastornos Generalizados del Desarrollo Infantil/inducido químicamente , Modelos Animales de Enfermedad , Femenino , Humanos , Relaciones Interpersonales , Masculino , Medicina Tradicional Coreana , Embarazo , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Ratas , Ratas Sprague-Dawley , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Cola (estructura animal)/anomalíasRESUMEN
BACKGROUND: Green tea extract (GTE) has been shown to have antioxidative properties due to its high content of polyphenols and catechin gallates. Previous studies indicated that catechin gallates scavenge free radicals and attenuate the effects of reactive oxygen species. Cyclophosphamide (CP) produces reactive oxidative species, which can have adverse effects on development, causing limb, digit, and cranial abnormalities. The current study was performed to determine if exposure to GTE can decrease teratogenic effects induced by CP in CD-1 mice. METHODS: From gestation days (GD) 6-13, mated CD-1 mice were dosed with 400 or 800 mg/kg/d GTE; 100, 200, 400, or 800 mg/kg/d GTE + CP; CP alone, or the vehicle. GTE was given by gavage. CP (20 mg/kg) was given by intraperitoneal injection on GD 10. Dams were sacrificed on GD 17, and their litters were examined for adverse effects. RESULTS: The highest GTE dose did not effectively attenuate, and in some cases exacerbated the negative effect of CP. GTE alone was also associated with an increased incidence of microblepharia. Conversely, moderate GTE doses (200 and/or 400 mg/kg/d) attenuated the effect of CP on fetal weight and (GTE 200 mg/kg/d) decreased the incidences of certain defects resulting from CP exposure. CONCLUSIONS: Exposure of a developing mammal to moderate doses of GTE can modulate the effects of exposure to CP during development, possibly by affecting biotransformation, while a higher GTE dose tended to exacerbate the developmental toxicity of CP. GTE alone appeared to cause an adverse effect on eyelid development.
Asunto(s)
Ciclofosfamida/toxicidad , Feto/anomalías , Feto/efectos de los fármacos , Exposición Materna , Extractos Vegetales/farmacología , Té/química , Animales , Extremidades/embriología , Extremidades/patología , Femenino , Feto/patología , Masculino , Ratones , Embarazo , Cola (estructura animal)/anomalías , Cola (estructura animal)/efectos de los fármacos , Cola (estructura animal)/embriologíaRESUMEN
AIMS OF STUDY: Retinoid-mediated signal transduction plays a crucial role in the embryogenesis of various organs. We previously reported the successful induction of anorectal malformations in mice using retinoic acid (RA). Retinoic acid controls the expression of essential target genes for cell differentiation, morphogenesis, and apoptosis through a complicated interaction in which RA receptors form heterodimers with retinoid X receptors. In the present study, we investigated whether the retinoid antagonist, LE135, could prevent the induction of anorectal malformations (ARMs) in mice. METHODS: Retinoic acid was intraperitoneally administered as 100 mg/kg of all-trans RA on E9; and then the retinoid antagonist, LE135, was intraperitoneally administered to pregnant ICR strain mice on the eighth gestational day (E8), 1 day before administration of RA (group B) or on E9, simultaneously (group C) with RA administration. All of the embryos were obtained from the uteri on E18. Frozen sections were evaluated for concentric layers around the endodermal epithelium by hematoxylin and eosin staining. RESULTS: In group A, all of the embryos demonstrated ARM with rectoprostatic urethral fistula, or rectocloacal fistula, and all of the embryos showed the absence of a tail. In group B, 36% of the embryos could be rescued from ARM. However, all of the rescued embryos had a short tail that was shorter than their hind limb. The ARM rescue rates in group B were significantly improved compared to those in group A (P < .01). In group C, 45% of the embryos were rescued from ARM, but all of the rescued embryos had short tail. The ARM rescue rate in group C was significantly improved compared to that in group A (P < .01). However, there was no significant difference in the ARM rescue rate between group B and Group C. CONCLUSION: The present study provides evidence that in the hindgut region, RAR selective retinoid antagonist, LE135, could rescue embryos from ARM. However, the disturbance of all-trans RA acid was limited to the caudal region. Further study to establish an appropriate rescue program for ARM in a mouse model might suggest a step toward protection against human ARM in the future.
Asunto(s)
Anomalías Inducidas por Medicamentos/prevención & control , Anomalías Múltiples/prevención & control , Canal Anal/anomalías , Dibenzazepinas/uso terapéutico , Receptores de Ácido Retinoico/antagonistas & inhibidores , Recto/anomalías , Tretinoina/toxicidad , Anomalías Inducidas por Medicamentos/embriología , Anomalías Inducidas por Medicamentos/etiología , Anomalías Múltiples/inducido químicamente , Anomalías Múltiples/embriología , Animales , Cloaca/anomalías , Cloaca/embriología , Dibenzazepinas/administración & dosificación , Dibenzazepinas/farmacología , Esquema de Medicación , Evaluación Preclínica de Medicamentos , Femenino , Fístula/inducido químicamente , Fístula/embriología , Fístula/prevención & control , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Humanos , Inyecciones Intraperitoneales , Masculino , Ratones , Ratones Endogámicos ICR , Modelos Animales , Embarazo , Enfermedades de la Próstata/inducido químicamente , Enfermedades de la Próstata/embriología , Enfermedades de la Próstata/prevención & control , Distribución Aleatoria , Fístula Rectal/inducido químicamente , Fístula Rectal/embriología , Fístula Rectal/prevención & control , Especificidad de la Especie , Cola (estructura animal)/anomalías , Tretinoina/administración & dosificaciónRESUMEN
Despite two decades of research since Smithells and colleagues began exploring its benefits, the mechanisms through which folic acid supplementation supports neural tube closure and early embryonic development are still unclear. The greatest progress toward a molecular-genetic understanding of folate effects on neural tube defect (NTD) pathogenesis has come from animal models. The number of NTD-associated mouse mutants accumulated and studied over the past decade has illuminated the complexity of both genetic factors contributing to NTDs and also NTD-gene interactions with folate metabolism. This article discusses insights gained from mouse models into how folate supplementation impacts neurulation. A case is made for renewed efforts to systematically screen the folate responsiveness of the scores of NTD-associated mouse mutations now identified. Designed after Crooked tail, supplementation studies of additional mouse mutants could build the molecular network maps that will ultimately enable tailoring of therapeutic regimens to individual families.
Asunto(s)
Suplementos Dietéticos , Ácido Fólico/farmacología , Redes y Vías Metabólicas/efectos de los fármacos , Defectos del Tubo Neural/metabolismo , Cola (estructura animal)/anomalías , Animales , Tipificación del Cuerpo/efectos de los fármacos , Tipificación del Cuerpo/genética , Femenino , Ácido Fólico/administración & dosificación , Predisposición Genética a la Enfermedad , Redes y Vías Metabólicas/genética , Ratones , Ratones Mutantes , Modelos Biológicos , Defectos del Tubo Neural/genética , Defectos del Tubo Neural/patología , Defectos del Tubo Neural/prevención & control , Embarazo , Cola (estructura animal)/metabolismoRESUMEN
Maternal administration of folic acid diminishes the risk of neural tube defects (NTDs) in offspring, but whether folic acid exerts a similar effect in diabetic pregnancy is unknown. The aim was to investigate whether maldevelopment in rat embryos caused by exposure to diabetes in vivo or high-glucose concentrations in vitro is affected by subcutaneous administration of folic acid to the pregnant mother or by adding the compound to the culture medium, respectively. Exposure of embryos to maternal diabetes in vivo or 30 mmol/l glucose in vitro yielded an increased malformation rate (71 and 88% NTD, respectively) and lowered somite number and crown-rump length compared with control embryos. When we injected folic acid into the diabetic pregnant rat, or added 2 mmol/l folic acid to the culture medium with high glucose, the embryonic parameters improved (3 and 5% NTD, respectively). The present work shows that administration of folic acid can diminish diabetes-induced maldevelopment. This suggests that folic acid supplementation may have a role in the prevention of malformations in diabetic pregnancy.
Asunto(s)
Anomalías Congénitas/etiología , Diabetes Mellitus Experimental/patología , Suplementos Dietéticos , Ácido Fólico/uso terapéutico , Glucosa/toxicidad , Embarazo en Diabéticas/fisiopatología , Animales , Anomalías Congénitas/prevención & control , Femenino , Defectos del Tubo Neural/etiología , Defectos del Tubo Neural/prevención & control , Embarazo , ARN/genética , ARN/aislamiento & purificación , Ratas , Cola (estructura animal)/anomalías , Cola (estructura animal)/embriologíaRESUMEN
BACKGROUND: Bent tail is a mouse model for X-linked neural tube defects (NTDs) that is characterized by the presence of exencephaly, a delayed posterior neuropore closure, and a tail phenotype. In addition, Bent tail shows laterality defects and increased prenatal mortality. The congenital malformations of this mouse are caused by a submicroscopic deletion that completely encompasses the gene coding for the zinc finger transcription factor Zic3. In this study we investigated the sensitivity of the phenotype of Bent tail to the nutrients folinic acid, myo-inositol, and zinc. These nutrients are thought to be involved in the etiology of NTDs, in combination with a genetic predisposition. METHODS: The most penetrant phenotype of the Bent tail mouse, the tail malformation, was used as a marker for the nutrient sensitivity of the neural phenotype. The size of the litters and the survival of the offspring, subdivided according to genotype, were analyzed as markers for the nutrient sensitivity of other phenotypic features of Bent tail. RESULTS: In confirmation of earlier studies, we observed the prenatal loss of a number of homozygous females and hemizygous males, as well as the effect of genotype on the tail phenotype of Bent tail. However, periconceptional supplementation of the maternal diet with folinic acid, myo-inositol, or zinc produced no significant effects on either the tail phenotype of the offspring or the size and genotypic composition of the litters. CONCLUSIONS: Bent tail appears to be a folinic acid-, myo-inositol-, and zinc-insensitive mouse model for NTDs.
Asunto(s)
Inositol/administración & dosificación , Leucovorina/administración & dosificación , Defectos del Tubo Neural/genética , Zinc/administración & dosificación , Animales , ADN/análisis , Dieta , Modelos Animales de Enfermedad , Pérdida del Embrión/genética , Femenino , Genotipo , Tamaño de la Camada/genética , Masculino , Ratones , Ratones Mutantes , Morfogénesis/genética , Defectos del Tubo Neural/patología , Embarazo , Cola (estructura animal)/anomalíasRESUMEN
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by degeneration of the anterior horn cells of the spinal cord, leading to muscular paralysis with muscular atrophy. No effective treatment of this disorder is presently available. Studies of the correlation between disease severity and the amount of survival motor neuron (SMN) protein have shown an inverse relationship. We report that sodium butyrate effectively increases the amount of exon 7-containing SMN protein in SMA lymphoid cell lines by changing the alternative splicing pattern of exon 7 in the SMN2 gene. In vivo, sodium butyrate treatment of SMA-like mice resulted in increased expression of SMN protein in motor neurons of the spinal cord and resulted in significant improvement of SMA clinical symptoms. Oral administration of sodium butyrate to intercrosses of heterozygous pregnant knockout-transgenic SMA-like mice decreased the birth rate of severe types of SMA-like mice, and SMA symptoms were ameliorated for all three types of SMA-like mice. These results suggest that sodium butyrate may be an effective drug for the treatment of human SMA patients.
Asunto(s)
Empalme Alternativo/efectos de los fármacos , Butiratos/uso terapéutico , Atrofia Muscular Espinal/tratamiento farmacológico , Proteínas del Tejido Nervioso/biosíntesis , Anomalías Múltiples/genética , Animales , Línea Celular Transformada/efectos de los fármacos , Cruzamientos Genéticos , Proteína de Unión a Elemento de Respuesta al AMP Cíclico , Evaluación Preclínica de Medicamentos , Elementos de Facilitación Genéticos , Inhibidores Enzimáticos/farmacología , Exones/genética , Femenino , Enfermedades Fetales/tratamiento farmacológico , Flavonoides/farmacología , Edad Gestacional , Cabello/anomalías , Humanos , Linfocitos/efectos de los fármacos , Linfocitos/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Intercambio Materno-Fetal , Ratones , Ratones Noqueados , Ratones Transgénicos , Atrofia Muscular Espinal/genética , Proteínas del Tejido Nervioso/deficiencia , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/fisiología , Ácido Ocadaico/farmacología , Fenotipo , Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Embarazo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Proteínas de Unión al ARN , Proteínas del Complejo SMN , Proteína 2 para la Supervivencia de la Neurona Motora , Cola (estructura animal)/anomalíasRESUMEN
Isotretinoin (13-cis-RA) is known to be teratogenic in humans and laboratory animals. The relatively low potency of 13-cis-RA in NRMI mice in comparison to the all-trans isomer has been proposed to be due to minimal transfer across the placenta (Creech-Kraft et al., '87). To further delineate the teratogenic potential of 13-cis-RA, a dose-response, temporal study was conducted in vivo and in vitro using submerged limb culture and image analysis evaluation of development. Dose-dependent embryotoxicity was produced by treatment on GD 7, while later treatments produced inconsistent effects on resorption rate and fetal weight. Treatment on either GD 7 or GD 8 produced a number of malformations in dose-dependent manner. Most common were tail and cleft palate defects, which were produced by 13-cis-RA on each of the days tested (GD 7-GD 11), with peak malformations occurring on GD 9 and GD 10 for tail and cleft palate, respectively. Most limb defects were produced after GD 10 and GD 11 exposure. The observed frequency of defects confirmed that in ICR mice 13-cis-RA is about 10-fold less potent than all-trans-RA as a limb teratogen (Kwasigroch and Kochhar, '80; Kochhar and Penner, '87). Effects observed via image analysis following maintenance of limbs in serum-free culture medium were dose dependent. Low dose treatment produced occasional polydactyly. The intermediate dose caused somewhat variable region-dependent increases in cartilaginous bone anlagen area. The high dose of 13-cis-RA produced irregular limb outlines, a reduction in bone anlagen area, and an inhibition of alcian blue staining of cartilage without affecting morphogenesis of bone anlagen. These results confirm that, when the effects of the administered doses are evaluated, 13-cis-RA is a much less potent teratogen in comparison to the all-trans isomer. More importantly, the results show that retinoids can enhance (at low and intermediate doses), depress (at high doses), or eliminate (high dose) chondrogenenic expression during limb morphogenesis in vitro. This indicates that retinoids such as 13-cis-RA can manipulate events in development in a variety of ways (i.e., produce malformations, interfere with chondrogenic expression without affecting morphogenesis, and stimulate growth) in a dose- and time-dependent manner. Although the ability of RA to act as a true morphogen has recently been questioned (Wanek et al., '91; Noji et al., '91), the results presented here support the position that RA can modulate the development of the limb (and probably other organ systems) in several vertebrate species.